News from benitec biopharma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Dec 21, 2018, 10:10 ET Benitec Provides Update on BB-401 Cancer Treatment Program

Benitec Biopharma (ASX: BLT, NADSAQ: BNTC) (the "Company"), a clinical-stage biotechnology company developing novel genetic medicines via the...


Jul 08, 2018, 20:59 ET Benitec Announces Global Licensing Agreement for BB-301 for Treatment of Oculopharyngeal Muscular Dystrophy and Broad Platform Collaboration with Axovant

Benitec Biopharma Limited ("Benitec" or the "Company") (ASX:BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today announced that it has licensed to Axovant...


May 24, 2016, 04:45 ET Benitec Biopharma Interim Report for the Nine Months Ended March 31, 2016

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today lodged its Interim Report for the nine months ended March 31, 2016. The...


Mar 08, 2016, 08:16 ET Benitec's Hepatitis B Therapy Reduces HBV DNA by 98.5% In Vivo

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) is pleased to announce that BB-HB-331, a DNA-directed RNA interference (ddRNAi)...


Feb 25, 2016, 06:42 ET Update on TT-034 Hepatitis C Clinical Trial

Benitec Biopharma (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) announced today that it will wind-down its hepatitis C program and terminate it upon...


Oct 19, 2015, 07:30 ET Benitec Forms Hepatology Clinical Advisory Board

Benitec Biopharma Limited (NASDAQ: BNTC; ASX: BLT), a clinical-stage biotechnology company developing innovative therapeutics based on its patented...


Oct 14, 2015, 08:00 ET Benitec Biopharma to Present at The 14th Annual BIO Investor Forum

Benitec Biopharma (ASX: BLT; NASDAQ: BNTC), a clinical-stage biotechnology company developing innovative therapeutics based on its gene silencing...


Feb 24, 2014, 07:30 ET Benitec Biopharma Announces Private Placement of Ordinary Shares and Warrants

Benitec Biopharma Limited (ASX: BLT), today announced it has completed a private placement of up to approximately 29.4 million of the company's...